Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herzog, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herzog, A. G.
NEUROLOGY 1988;38:432
© 1988 American Academy of Neurology

Clomiphene therapy in epileptic women with menstrual disorders

Andrew G. Herzog, MD

From the Neuroendocrine Section, Neurological Unit, Charles A. Dana Research Institute, Beth Israel Hospital, and the Department of Neurology, Harvard Medical School, Boston, MA.

We studied the effects of clomiphene therapy on seizure frequency in 12 women who had clinical and EEG features of complex partial seizures as well as menstrual disorders with reproductive endocrine abnormalities. Ten of the 12 women improved (p < 0. 05); all ten developed normal cycles. The two women who did not improve continued to have irregular prolonged cycles. Average monthly seizure frequency for the entire group declined by 87% (p < 0. 01). Both complex partial and secondary generalized seizures decreased. During the investigation, one unwanted pregnancy occurred, two women developed severe abdominal pain with ultrasound-documented ovarian cysts, and three experienced breast tenderness and pelvic cramps.

Address correspondence and reprint requests to Dr. Herzog, Neurological Unit, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215.

Presented in part at the thirty-ninth annual meeting of the American Academy of Neurology, New York, NY, April 1987.

Received May 29, 1987. Accepted for publication in final form July 2, 1987.




This article has been cited by other articles:


Home page
NeuroscientistHome page
J. Veliskova
Estrogens and Epilepsy: Why Are We So Excited?
Neuroscientist, February 1, 2007; 13(1): 77 - 88.
[Abstract] [PDF]


Home page
NeurologyHome page
N. Foldvary-Schaefer and T. Falcone
Catamenial epilepsy: Pathophysiology, diagnosis, and management
Neurology, September 1, 2003; 61(90062): S2 - 15.
[Abstract] [Full Text]


Home page
PsychosomaticsHome page
A. G. Herzog
Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part III: Case Reports
Psychosomatics, April 1, 1999; 40(2): 109 - 116.
[Abstract] [Full Text]


Home page
BMJHome page
M R Rimmington, S J Vine, D K C Chui, and S M Walker
Drug Points: Convulsions after clomiphene citrate
BMJ, August 20, 1994; 309(6953): 512c - 512.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.